Harpoon Therapeutics (NASDAQ:HARP – Get Rating)‘s stock had its “reiterates” rating reiterated by equities research analysts at 500.com in a note issued to investors on Monday, Benzinga reports. Several other analysts also recently weighed in on the company. HC Wainwright dropped their price objective on Harpoon Therapeutics from $7.00 to $4.50 and set a “buy” […]
Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Rating) was the recipient of a large growth in short interest in April. As of April 30th, there was short interest totalling 761,200 shares, a growth of 115.5% from the April 15th total of 353,200 shares. Based on an average daily trading volume, of 305,500 shares, the short-interest ratio […]
Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Rating) saw a significant increase in short interest in April. As of April 30th, there was short interest totalling 761,200 shares, an increase of 115.5% from the April 15th total of 353,200 shares. Currently, 3.3% of the company’s stock are sold short. Based on an average daily volume of […]
Harpoon Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.